The embargo on all abstracts accepted to the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium will lift at 5:00 p.m. ET on Monday, February 3, 2020.
Attend the Meeting in Person
Media registration for the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium is now open. At this time, you can visit ASCO's Media Headquarters to apply for media credentials*, register to attend an upcoming meeting, and access embargoed meeting information. For questions about how to navigate the site, please contact ASCO Media Registration.
*If you attended the 2019 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information. You only have to register if you want to attend the Symposium in person in Orlando.
Access Embargoed Information
Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
New Research Shows Progress Toward Identifying Predictive Biomarkers for Immunotherapies
Developing and validating predictive markers for treatment outcomes and then confirming how those markers can be used to help patients and clinicians choose appropriate therapies is often a long step-wise process. New research presented at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium points to multiple potential approaches for determining which patients are most likely to benefit from immunotherapy. Read the full Cancer Perspectives article.